Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation

Nature Immunology volume 10, pages 595–602 (2009)Cite this article

Abstract

Several subsets of Foxp3+ regulatory T cells (Treg cells) work in concert to maintain immune homeostasis. However, the molecular bases underlying the phenotypic and functional diversity of Treg cells remain obscure. We show that in response to interferon-γ, Foxp3+ Treg cells upregulated the T helper type 1 (TH1)-specifying transcription factor T-bet. T-bet promoted expression of the chemokine receptor CXCR3 on Treg cells, and T-bet+ Treg cells accumulated at sites of TH1 cell–mediated inflammation. Furthermore, T-bet expression was required for the homeostasis and function of Treg cells during type 1 inflammation. Thus, in a subset of CD4+ T cells, the activities of the transcription factors Foxp3 and T-bet are overlaid, which results in Treg cells with unique homeostatic and migratory properties optimized for the suppression of TH1 responses in vivo.

Access through your institution
Buy or subscribe

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: CXCR3 expression on Treg cells is T-bet dependent.
Figure 2: Treg cells upregulate T-bet in vivo after treatment with anti-CD40.
Figure 3: IFN-γR and STAT1 promote the expression of T-bet and CXCR3 by Treg cells.
Figure 4: Functional characterization of T-bet+ Foxp3+ Treg cells.
Figure 5: Impaired proliferation of T-bet-deficient Treg cells after treatment with anti-CD40.
Figure 6: Impaired homeostasis of T-bet-deficient Treg cells during persistent infection with M. tuberculosis.
Figure 7: T-bet expression in Treg cells is critical for control of TH1 cell–mediated inflammatory responses.

Similar content being viewed by others

References

  1. Wilson, C.B., Rowell, E. & Sekimata, M. Epigenetic control of T-helper-cell differentiation. Nat. Rev. Immunol. 9, 91–105 (2009).

    Article  CAS  PubMed  Google Scholar 

  2. Reiner, S.L. Development in motion: helper T cells at work. Cell 129, 33–36 (2007).

    Article  CAS  PubMed  Google Scholar 

  3. Szabo, S.J. et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 100, 655–669 (2000).

    Article  CAS  PubMed  Google Scholar 

  4. Beima, K.M. et al. T-bet binding to newly identified target gene promoters is cell type-independent but results in variable context-dependent functional effects. J. Biol. Chem. 281, 11992–12000 (2006).

    Article  CAS  PubMed  Google Scholar 

  5. Sakaguchi, S., Yamaguchi, T., Nomura, T. & Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775–787 (2008).

    Article  CAS  PubMed  Google Scholar 

  6. Zheng, Y. et al. Genome-wide analysis of Foxp3 target genes in developing and mature regulatory T cells. Nature 445, 936–940 (2007).

    Article  CAS  PubMed  Google Scholar 

  7. Marson, A. et al. Foxp3 occupancy and regulation of key target genes during T-cell stimulation. Nature 445, 931–935 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Fontenot, J.D., Gavin, M.A. & Rudensky, A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat. Immunol. 4, 330–336 (2003).

    Article  CAS  PubMed  Google Scholar 

  9. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057–1061 (2003).

    Article  CAS  PubMed  Google Scholar 

  10. Bennett, C.L. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20–21 (2001).

    Article  CAS  PubMed  Google Scholar 

  11. Wildin, R.S. et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27, 18–20 (2001).

    Article  CAS  PubMed  Google Scholar 

  12. Jankovic, D. et al. Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection. J. Exp. Med. 204, 273–283 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Anderson, C.F., Oukka, M., Kuchroo, V.J. & Sacks, D. CD4+CD25−Foxp3− Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis. J. Exp. Med. 204, 285–297 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Siegmund, K. et al. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106, 3097–3104 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Sarween, N. et al. CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173, 2942–2951 (2004).

    Article  CAS  PubMed  Google Scholar 

  16. Belkaid, Y. Regulatory T cells and infection: a dangerous necessity. Nat. Rev. Immunol. 7, 875–888 (2007).

    Article  CAS  PubMed  Google Scholar 

  17. Scott-Browne, J.P. et al. Expansion and function of Foxp3-expressing T regulatory cells during tuberculosis. J. Exp. Med. 204, 2159–2169 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Zheng, Y. et al. Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control TH2 responses. Nature 458, 351–356 (2009).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Williams, L.M. & Rudensky, A.Y. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3. Nat. Immunol. 8, 277–284 (2007).

    Article  CAS  PubMed  Google Scholar 

  20. Huehn, J. et al. Developmental stage, phenotype, and migration distinguish naive- and effector/memory-like CD4+ regulatory T cells. J. Exp. Med. 199, 303–313 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Sather, B.D. et al. Altering the distribution of Foxp3+ regulatory T cells results in tissue-specific inflammatory disease. J. Exp. Med. 204, 1335–1347 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Dudda, J.C., Perdue, N., Bachtanian, E. & Campbell, D.J. Foxp3+ regulatory T cells maintain immune homeostasis in the skin. J. Exp. Med. 205, 1559–1565 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Lee, I. et al. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201, 1037–1044 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Suffia, I., Reckling, S.K., Salay, G. & Belkaid, Y. A role for CD103 in the retention of CD4+CD25+ Treg and control of Leishmania major infection. J. Immunol. 174, 5444–5455 (2005).

    Article  CAS  PubMed  Google Scholar 

  25. Yuan, Q. et al. CCR4-dependent regulatory T cell function in inflammatory bowel disease. J. Exp. Med. 204, 1327–1334 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Rubtsov, Y.P. et al. Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. Immunity 28, 546–558 (2008).

    Article  CAS  PubMed  Google Scholar 

  27. Cole, K.E. et al. Interferon-inducible T cell α chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187, 2009–2021 (1998).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Farber, J.M. A macrophage mRNA selectively induced by γ-interferon encodes a member of the platelet factor 4 family of cytokines. Proc. Natl. Acad. Sci. USA 87, 5238–5242 (1990).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Luster, A.D., Unkeless, J.C. & Ravetch, J.V. Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315, 672–676 (1985).

    Article  CAS  PubMed  Google Scholar 

  30. Lord, G.M. et al. T-bet is required for optimal proinflammatory CD4+ T-cell trafficking. Blood 106, 3432–3439 (2005).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Ferlin, W.G. et al. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb. Eur. J. Immunol. 28, 525–531 (1998).

    Article  CAS  PubMed  Google Scholar 

  32. Boyman, O., Kovar, M., Rubinstein, M.P., Surh, C.D. & Sprent, J. Selective stimulation of T cell subsets with antibody-cytokine immune complexes. Science 311, 1924–1927 (2006).

    Article  CAS  PubMed  Google Scholar 

  33. Afkarian, M. et al. T-bet is a STAT1-induced regulator of IL-12R expression in naive CD4+ T cells. Nat. Immunol. 3, 549–557 (2002).

    Article  CAS  PubMed  Google Scholar 

  34. Mullen, A.C. et al. Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. Science 292, 1907–1910 (2001).

    Article  CAS  PubMed  Google Scholar 

  35. Szabo, S.J. et al. Distinct effects of T-bet in TH1 lineage commitment and IFN-γ production in CD4 and CD8 T cells. Science 295, 338–342 (2002).

    Article  CAS  PubMed  Google Scholar 

  36. Hancock, W.W. et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J. Exp. Med. 192, 1515–1520 (2000).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Yoneyama, H. et al. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J. Exp. Med. 195, 1257–1266 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Kursar, M. et al. Cutting edge: regulatory T cells prevent efficient clearance of Mycobacterium tuberculosis. J. Immunol. 178, 2661–2665 (2007).

    Article  CAS  PubMed  Google Scholar 

  39. Zhou, B. et al. Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice. Nat. Immunol. 6, 1047–1053 (2005).

    Article  CAS  PubMed  Google Scholar 

  40. Bettelli, E. et al. Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 200, 79–87 (2004).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Neurath, M.F. et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 195, 1129–1143 (2002).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Garrett, W.S. et al. Communicable ulcerative colitis induced by T-bet deficiency in the innate immune system. Cell 131, 33–45 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Finotto, S. et al. Asthmatic changes in mice lacking T-bet are mediated by IL-13. Int. Immunol. 17, 993–1007 (2005).

    Article  CAS  PubMed  Google Scholar 

  44. Godfrey, V.L., Wilkinson, J.E. & Russell, L.B. X-linked lymphoreticular disease in the scurfy (sf) mutant mouse. Am. J. Pathol. 138, 1379–1387 (1991).

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Muller, M. et al. CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system. J. Immunol. 179, 2774–2786 (2007).

    Article  PubMed  Google Scholar 

  46. Santodomingo-Garzon, T., Han, J., Le, T., Yang, Y. & Swain, M.G. Natural killer T cells regulate the homing of chemokine CXC receptor 3-positive regulatory T cells to the liver in mice. Hepatology 49, 1267–1276 (2009).

    Article  CAS  PubMed  Google Scholar 

  47. Townsend, M.J. et al. T-bet regulates the terminal maturation and homeostasis of NK and Vα14i NKT cells. Immunity 20, 477–494 (2004).

    Article  CAS  PubMed  Google Scholar 

  48. Burchill, M.A., Yang, J., Vogtenhuber, C., Blazar, B.R. & Farrar, M.A. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J. Immunol. 178, 280–290 (2007).

    Article  CAS  PubMed  Google Scholar 

  49. Wei, G. et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30, 155–167 (2009).

    Article  PubMed  PubMed Central  Google Scholar 

  50. Ono, M. et al. Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1. Nature 446, 685–689 (2007).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank A. Weinmann (University of Washington) for Tbx21−/− mice; A. Rudensky (University of Washington) for Foxp3GFP mice; S. Ziegler (Benaroya Research Institute) for mice with overexpression of thymic stromal lymphopoietin and for Il4−/− and Stat6−/− mice; M. Krishna-Kaja (University of Washington) for splenocytes from Stat1−/− mice; L. Thompson and K. Smigiel for technical assistance; G. Debes, K. Klonowski and J. Hamerman for comments on the manuscript; and M. Warren for administrative assistance. Supported by the US National Institutes of Health (DK072295, AI067750 and AI069889 to D.J.C.), the US Department of Defense (USAMRAA W81XWH-07-0246 to D.J.C.), the Burroughs-Wellcome Fund (K.B.U.) and the Department of Immunology at the University of Washington Medical School (T32-CA009537 to M.A.K.).

Author information

Authors and Affiliations

  1. Benaroya Research Institute, Seattle, Washington, USA

    Meghan A Koch, Nikole R Perdue, Justin R Killebrew & Daniel J Campbell

  2. Department of Immunology, University of Washington School of Medicine, Seattle, Washington, USA

    Meghan A Koch, Justin R Killebrew & Daniel J Campbell

  3. Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington, USA

    Glady's Tucker-Heard & Kevin B Urdahl

Authors
  1. Meghan A Koch
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. Glady's Tucker-Heard
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Nikole R Perdue
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Justin R Killebrew
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Kevin B Urdahl
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Daniel J Campbell
    View author publications

    You can also search for this author inPubMed Google Scholar

Contributions

M.A.K., K.B.U. and D.J.C. designed the study, analyzed data and wrote the manuscript, and M.A.K. and D.J.C. did experiments with assistance from N.R.P., J.R.K. and G.T-H.

Corresponding author

Correspondence to Daniel J Campbell.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–11 and Supplementary Table 1 (PDF 590 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koch, M., Tucker-Heard, G., Perdue, N. et al. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 10, 595–602 (2009). https://doi.org/10.1038/ni.1731

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni.1731

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing